Biotech Bubble Buckles: Tumbles Almost 7% To 3-Week Lows

Biotech stocks have been surging since their mid-March plunge, but it appears that is at an end as XBI - the SPDR Biotech ETF - is now down almost 7% from Friday's highs on heavy volume (and back below the 50DMA once again).
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.